AKBA News and Press, Akebia Therapeutics Inc.

Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference PR Newswire CAMBRIDGE, Mass. , June 27, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purp...

2024-06-24 09:37:22 ET More on Akebia Buy Vafseo's Approval: A New Chapter For Akebia Therapeutics In Anemia Management Akebia's Vafseo Faces Grim Market Outlook (Rating Downgrade) Read the full article on Seeking Alpha For further details see: Akebia The...

Akebia Therapeutics Appoints Erik Ostrowski as Chief Financial Officer and Chief Business Officer PR Newswire CAMBRIDGE, Mass. , June 24, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with t...

2024-06-09 08:01:00 ET More on companies reporting earnings during the week FuelCell Energy: Consider Potential Q2 Results Miss And Korean Market Opportunities Oracle: Strong EPS Growth Expected In 2025 And 2026, Watching Q4 Margins (Rating Upgrade) Broadcom: It's To...

Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference PR Newswire CAMBRIDGE, Mass. , May 23, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better t...

Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference PR Newswire CAMBRIDGE, Mass. , May 14, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to b...

2024-05-09 11:57:22 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Akebia Therapeutics (NASDAQ: AKBA ) just reported results for the first quarter of 2024. Akebia Therapeutics reported earnings per share of -9 cents. This was below the an...

2024-05-09 10:54:12 ET Akebia Therapeutics, Inc. (AKBA) Q1 2024 Earnings Conference Call May 09, 2024, 8:00 AM ET Company Participants Mercedes Carrasco - Senior Director, Corporate Communications and IR John Butler - President and Chief Executive Officer Nichola...

2024-05-09 10:00:35 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 16 out...

2024-05-09 07:21:26 ET More on Akebia Buy Vafseo's Approval: A New Chapter For Akebia Therapeutics In Anemia Management Akebia's Vafseo Faces Grim Market Outlook (Rating Downgrade) Akebia Q1 2024 Earnings Preview Akebia stock jumps as FDA clears renal anemia ...